These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5454001)

  • 1. [The blood cogulation and fibrinolytic enzyme system during and after extracorporeal circulation].
    Goldschmidt B; Böröcz L; Haas M; Büky B
    Orv Hetil; 1970 May; 111(18):1027-30. PubMed ID: 5454001
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
    Deutschinoff A; Dimitrov D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):166-73. PubMed ID: 4174654
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood coagulation and fibrinolytic enzyme systems during and after extracorporeal circulation].
    Goldschmidt B; Böröcz L; Haas M; Büky B
    Thoraxchir Vask Chir; 1970 Dec; 18(6):510-9. PubMed ID: 5275551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies on the changes in clotting factor before and after extracorporeal circulation].
    Orumuka Y
    Kumamoto Igakkai Zasshi; 1970 Jun; 44(6):497-511. PubMed ID: 5468447
    [No Abstract]   [Full Text] [Related]  

  • 5. [Premises to the study of blood coagulation changes in the course of extracorporeal circulation].
    Respighi E; Marcazzan E; Panzeri E
    Arch Chir Torac Cardiovasc; 1968; 25(3):207-27. PubMed ID: 4910329
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemostatic changes in extracorporeal surgery: pathogenesis and treatment].
    Páramo JA; Rifón J; Rocha E
    Sangre (Barc); 1993 Jun; 38(3):225-31. PubMed ID: 8211549
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinolytic hemorrhages in childhood and their therapy with PAMBA].
    Hoffmann W; Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):88-93. PubMed ID: 4173887
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antifibrinolytic agents and extracorporeal circulation].
    Gomes OM; Freitas Neto AG; Wolosker M; Langer B; Dubieu WK; Zerbini EJ
    Rev Hosp Clin Fac Med Sao Paulo; 1972; 27(5):209-13. PubMed ID: 4538812
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of plasmatic fibrinolytic activity after adeno-tonsillectomy].
    Conticello S; Lombardo C; Terranova R
    Ann Laringol Otol Rinol Faringol; 1967; 66(3):373-9. PubMed ID: 5632639
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass.
    Porter JM; Silver D
    J Thorac Cardiovasc Surg; 1968 Dec; 56(6):869-78. PubMed ID: 5722114
    [No Abstract]   [Full Text] [Related]  

  • 11. [The importance of fibrinopathies during cardiac surgery under extracorporeal circulation].
    Broustet P; Fontan F; Bricaud H; Trarieux M; Ploquin F
    Bord Med; 1970 Nov; 3(11):2577-8 passim. PubMed ID: 5510142
    [No Abstract]   [Full Text] [Related]  

  • 12. [Impaired hemostasis as a cause of intensified bleeding after heart surgery with extracorporeal blood circulation].
    Morozov IuA; Charnaia MA; Gladysheva VG
    Anesteziol Reanimatol; 2004; (2):30-2. PubMed ID: 15206273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorrhages caused by hyperfibrinolysis and their treatment].
    Teofili MT; Tucci G
    Clin Ter; 1968 Sep; 46(6):563-84. PubMed ID: 4914362
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on an antifibrinolytic agent trans-AMCHA.
    Sunada T; Shimizu H; Morimoto S; Shigemoto H; Fujiyama N
    Acta Med Okayama (1952); 1968 Dec; 22(6):331-7. PubMed ID: 4240920
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rheological properties of the blood in patients undergoing surgery with extracorporeal circulation].
    Savel'ev VS; Gologorskiĭ VA; Aleksandrova NP; Shestakov VA; Il'in SG
    Grudn Khir; 1977; (5):39-48. PubMed ID: 914068
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems of fibrinolysis in extracorporeal circulation. Clinical and experimental research].
    Ghilardi F; Del Fante FM; Indrio MG; Marchisio O
    Minerva Anestesiol; 1966 Oct; 32(10):577-84. PubMed ID: 5994090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes of blood coagulation in prostatic surgery, consequences for preventive therapy with antifibrinolytic agents].
    Naber K; Bichler KH; Müller KH; Sommerkamp H; Jöhrens H; Porzsolt F
    Helv Chir Acta; 1973 Sep; 40(4):519-22. PubMed ID: 4753393
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of trasylol as an inhibitor of proteases of the fibrinolysis system during extracorporeal circulation].
    Masiak M; Bross W
    Folia Med Cracov; 1980; 22(3-4):455-61. PubMed ID: 6169610
    [No Abstract]   [Full Text] [Related]  

  • 19. [Classification and management of hemorrhagic syndromes after surgery with extracorporeal circulation].
    Gallucci C; Forte V; Buffollo E; Catani R; Godoy MF; Guerra C; Silva MP
    Arq Bras Cardiol; 1972 Aug; 25(4):287-93. PubMed ID: 4644464
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reasons for increased bleeding after heart surgery under conditions of extracorporeal circulation].
    Solov'ev GM; Khodas MIa; Piatnitskaia GKh; Dement'eva II
    Grudn Khir; 1970; 12(4):3-9. PubMed ID: 5479811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.